A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD
Phase 3
Completed
- Conditions
- COPD
- Registration Number
- NCT00308191
- Lead Sponsor
- Dey
- Brief Summary
The purpose of this study is to evaluate the safety and efficacy of the concomitant treatment of formoterol fumarate with tiotropium bromide compared to treatment with tiotropium bromide alone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
- Medical diagnosis of COPD
- Current or prior history of cigarette smoking
Exclusion Criteria
- Medical diagnosis of asthma
- Significant condition or disease other than COPD
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Measure of lung Function
- Secondary Outcome Measures
Name Time Method Change in lung function, vital signs; physical examinations; clinical laboratory assessments; adverse event reporting; patient questionnaires
Trial Locations
- Locations (1)
Research Site
🇺🇸San Antonio, Texas, United States